Duarte Ira
EVP, Chief Financial Officer · 12 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-16 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Tax withholding | 3,555 | $0.38 | $1,350.90 | filing |
| 2026-06-16 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Option exercise | 12,500 | — | — | filing |
| 2026-04-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Option exercise | 11,694 | — | — | filing |
| 2026-04-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Option exercise | 13,535 | — | — | filing |
| 2026-04-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Option exercise | 3,874 | — | — | filing |
| 2026-01-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Option exercise | 11,695 | — | — | filing |
| 2026-01-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Option exercise | 3,875 | — | — | filing |
| 2025-10-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Option exercise | 11,694 | — | — | filing |
| 2025-10-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Option exercise | 3,874 | — | — | filing |
| 2025-07-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Option exercise | 11,695 | — | — | filing |
| 2025-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Option exercise | 3,874 | — | — | filing |
| 2025-06-16 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Option exercise | 12,500 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.